rxstat › Prices in Ontario › Methylphenidate
Methylphenidate (Concerta) price and coverage in Ontario
Methylphenidate 18 mg tablet (extended-release) lists at $0.52 per tablet in Ontario on the Ontario Drug Benefit (ODB) program's price list (Oct 30, 2026), before the pharmacy's dispensing fee. The brand (Concerta) lists at $3.30.
Methylphenidate is covered by the Ontario Drug Benefit (ODB) program as a regular benefit.
How it compares across Canada
| Alberta | $0.52/tablet |
| Manitoba | $0.52/tablet |
| Ontario | $0.52/tablet |
| New Brunswick | $0.52/tablet |
| Nova Scotia | $0.52/tablet |
| Prince Edward Island | $0.52/tablet |
| British Columbia | $0.57/tablet |
| Newfoundland and Labrador | $0.57/tablet |
| Saskatchewan | $3.30/tablet |
Price by strength in Ontario
| Strength and form | Lowest price | Brand |
|---|---|---|
| 18 mg Tablet (Extended-Release)4 products · covered | $0.52/tablet | $3.30Concerta |
| 27 mg Tablet (Extended-Release)4 products · covered | $0.61/tablet | $3.81Concerta |
| 36 mg Tablet (Extended-Release)4 products · covered | $0.69/tablet | $4.32Concerta |
| 54 mg Tablet (Extended-Release)4 products · covered | $0.85/tablet | $5.33Concerta |
| 20 mg Tablet3 products · not covered | $0.35/tablet | – |
| 10 mg Tablet3 products · covered | $0.22/tablet | – |
| 20 mg Tablet (Extended-Release)2 products · covered | $0.68/tablet | – |
| 10 mg Capsule (Extended-Release)2 products · covered | $0.51/capsule | $1.03Biphentin |
| 15 mg Capsule (Extended-Release)2 products · covered | $0.74/capsule | $1.48Biphentin |
| 20 mg Capsule (Extended-Release)2 products · covered | $0.95/capsule | $1.90Biphentin |
| 30 mg Capsule (Extended-Release)2 products · covered | $1.30/capsule | $2.61Biphentin |
| 40 mg Capsule (Extended-Release)2 products · covered | $1.66/capsule | $3.33Biphentin |
| 50 mg Capsule (Extended-Release)2 products · covered | $2.01/capsule | $4.04Biphentin |
| 60 mg Capsule (Extended-Release)2 products · covered | $2.34/capsule | $4.70Biphentin |
| 80 mg Capsule (Extended-Release)2 products · covered | $3.09/capsule | $6.19Biphentin |
| 25 mg Capsule (Controlled-Release)1 product · covered | $3.04/capsule | – |
| 35 mg Capsule (Controlled-Release)1 product · covered | $3.34/capsule | – |
| 45 mg Capsule (Controlled-Release)1 product · covered | $3.63/capsule | – |
| 55 mg Capsule (Controlled-Release)1 product · covered | $3.93/capsule | – |
| 70 mg Capsule (Controlled-Release)1 product · covered | $4.38/capsule | – |
| 85 mg Capsule (Controlled-Release)1 product · covered | $4.82/capsule | – |
| 100 mg Capsule (Controlled-Release)1 product · covered | $5.25/capsule | – |
All 47 products listed in Ontario
| Product | Price | Coverage |
|---|---|---|
| 18 mg Tablet (Extended-Release) | ||
| Act Methylphenidate ErTeva Canada Limited · DIN 02441934 | $0.52/tablet | Covered |
| Apo-Methylphenidate ErApotex Inc. · DIN 02452731 | $0.52/tablet | Covered |
| Taro-Methylphenidate ErSun Pharma · DIN 02539004 | $0.52/tablet | Covered |
| ConcertaJanssen Inc. · DIN 02247732 | $3.30/tablet | Covered |
| 27 mg Tablet (Extended-Release) | ||
| Act Methylphenidate ErTeva Canada Limited · DIN 02441942 | $0.61/tablet | Covered |
| Apo-Methylphenidate ErApotex Inc. · DIN 02452758 | $0.61/tablet | Covered |
| Taro-Methylphenidate ErSun Pharma · DIN 02539012 | $0.61/tablet | Covered |
| ConcertaJanssen Inc. · DIN 02250241 | $3.81/tablet | Covered |
| 36 mg Tablet (Extended-Release) | ||
| Act Methylphenidate ErTeva Canada Limited · DIN 02441950 | $0.69/tablet | Covered |
| Apo-Methylphenidate ErApotex Inc. · DIN 02452766 | $0.69/tablet | Covered |
| Taro-Methylphenidate ErSun Pharma · DIN 02539020 | $0.69/tablet | Covered |
| ConcertaJanssen Inc. · DIN 02247733 | $4.32/tablet | Covered |
| 54 mg Tablet (Extended-Release) | ||
| Apo-Methylphenidate ErApotex Inc. · DIN 02330377 | $0.85/tablet | Covered |
| Act Methylphenidate ErTeva Canada Limited · DIN 02441969 | $0.85/tablet | Covered |
| Taro-Methylphenidate ErSun Pharma · DIN 02539039 | $0.85/tablet | Covered |
| ConcertaJanssen Inc. · DIN 02247734 | $5.33/tablet | Covered |
| 20 mg Tablet | ||
| Pms-MethylphenidatePharmascience Inc. · DIN 00585009 | $0.35/tablet | Not covered |
| Apo-MethylphenidateApotex Inc. · DIN 02249332 | $0.35/tablet | Not covered |
| Ritalin 20mgNovartis Pharma Canada Inc. · DIN 00005614 | – | Not covered |
| 10 mg Tablet | ||
| Pms-MethylphenidatePharmascience Inc. · DIN 00584991 | $0.22/tablet | Covered |
| Apo-MethylphenidateApotex Inc. · DIN 02249324 | $0.22/tablet | Covered |
| Ritalin 10mgNovartis Pharma Canada Inc. · DIN 00005606 | $0.46/tablet | Covered |
| 20 mg Tablet (Extended-Release) | ||
| Aa-Methylphenidate SrA A Pharma Inc. · DIN 02266687 | $0.68/tablet | Covered |
| Ritalin-Sr Tab 20mgNovartis Pharma Canada Inc. · DIN 00632775 | – | Not covered |
| 10 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02536943 | $0.51/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277166 | $1.03/capsule | Covered |
| 15 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02536951 | $0.74/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277131 | $1.48/capsule | Covered |
| 20 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02536978 | $0.95/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277158 | $1.90/capsule | Covered |
| 30 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02536986 | $1.30/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277174 | $2.61/capsule | Covered |
| 40 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02536994 | $1.66/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277182 | $3.33/capsule | Covered |
| 50 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02537001 | $2.01/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277190 | $4.04/capsule | Covered |
| 60 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02537028 | $2.34/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277204 | $4.70/capsule | Covered |
| 80 mg Capsule (Extended-Release) | ||
| Pms-Methylphenidate CrPharmascience Inc. · DIN 02537036 | $3.09/capsule | Covered |
| BiphentinElvium Life Sciences · DIN 02277212 | $6.19/capsule | Covered |
| 25 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470292 | $3.04/capsule | Covered |
| 35 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470306 | $3.34/capsule | Covered |
| 45 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470314 | $3.63/capsule | Covered |
| 55 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470322 | $3.93/capsule | Covered |
| 70 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470330 | $4.38/capsule | Covered |
| 85 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470349 | $4.82/capsule | Covered |
| 100 mg Capsule (Controlled-Release) | ||
| FoquestElvium Life Sciences · DIN 02470357 | $5.25/capsule | Covered |
ODB pays only up to the lowest-cost interchangeable price ($0.22 per tablet for 10 mg); if you choose the brand, you pay the difference.
What you'll pay at the pharmacy
These are the prices the Ontario Drug Benefit (ODB) program lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
Partial shortage Supply is affected in Canada: see shortage status.
Methylphenidate price in other provinces
Common questions
How much does Methylphenidate cost in Ontario?
Methylphenidate 18 mg tablet (extended-release) lists at $0.52 per tablet in Ontario on the Ontario Drug Benefit (ODB) program's price list (Oct 30, 2026), before the pharmacy's dispensing fee. The brand (Concerta) lists at $3.30.
Is Methylphenidate covered in Ontario?
Methylphenidate is covered by the Ontario Drug Benefit (ODB) program as a regular benefit.
Is Methylphenidate cheaper in another province?
For 18 mg tablet (extended-release), listed prices run from $0.52 to $3.30 across 9 provinces. Public plans only cover their own residents, though.
Source: Ontario Drug Benefit Formulary (Oct 30, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.